Does washing the biopsy needle with povidone-iodine have an effect on infection rates after transrectal prostate needle biopsy?

Urologia Internationalis

Volumn 85, Issue 2, 2010, Pages 147-151

  Koc, Gokhan ^a   Un, Sitki ^a   Filiz, Devrim Nihat ^a   Akbay, Kaan ^a   Yilmaz, Yuksel ^a  

^a Tepecik Teaching and Research Hospital ^*  (Turkey)

Author keywords

Antibiotic prophylaxis; Povidone iodine; Prostatic biopsy

Indexed keywords

CIPROFLOXACIN; POVIDONE IODINE; PROSTATE SPECIFIC ANTIGEN;

ADULT; AGED; ANTIBIOTIC PROPHYLAXIS; ARTICLE; CLEANING; CONTROLLED STUDY; HEMATURIA; HUMAN; INFECTION RATE; MAJOR CLINICAL STUDY; MALE; MEDICAL INSTRUMENTATION; NEEDLE; NEEDLE BIOPSY; PRIORITY JOURNAL; PROSTATE BIOPSY; URINARY TRACT INFECTION; URINE CULTURE;

AGED; ANTIBIOTIC PROPHYLAXIS; BACTERIAL INFECTIONS; BIOPSY, NEEDLE; CHI-SQUARE DISTRIBUTION; DISINFECTANTS; ENEMA; EQUIPMENT CONTAMINATION; HUMANS; MALE; MIDDLE AGED; NEEDLES; POVIDONE-IODINE; PROSTATE; TIME FACTORS; TURKEY; ULTRASONOGRAPHY, INTERVENTIONAL;

EID: 77957274278     PISSN: 00421138     EISSN: None     Source Type: Journal    
DOI: 10.1159/000314340     Document Type: Article

References (34)

1. Matlaga BR, Eskew LA, McCullough DL: Prostate biopsy: Indications and technique. J Urol 2003; 169: 12-19.
2. Aron M, Rajeev TP, Gupta NP: Antibiotic prophylaxis for transrectal needle biopsy of the prostate: A randomized controlled study. BJU Int 2000; 85: 682-685. (Pubitemid 30192834)
3. Puig J, Darnell A, Bermudez P, et al: Transrectal ultrasound guided prostate biopsy: Is antibiotic prophylaxis necessary? Eur Radiol 2006; 16: 939-943. (Pubitemid 43380254)
4. Wolf JS Jr, Bennett CJ, Dmochowski RR, Hollenbeck BK, Pearle MS, Schaeffer AJ, Urologic Surgery Antimicrobial Prophylaxis Best Practice Policy Panel: Best practice policy statement on urologic surgery antimicrobial propylaxis. J Urol 2008; 179: 1379-1390.
5. Bootsma AM, Laguna Pes MP, Geerlings SE, Goossens A: Antibiotic prophylaxis in urologic procedures. A systematic review. Eur Urol 2008; 54: 1270-1286.
6. NHS: Undertaking a transrectal ultrasound guided biopsy of the prostate. http//www. cancerscreening.nhs.uk/prostate/pcbs01. html (accessed October 29, 2007).
7. Tal R, Livne P, Lask D, Baniel J: Empirical management of urinary tract infections complicating transrectal ultrasound guided prostate biopsy. J Urol 2003; 169: 1762-1765. (Pubitemid 36443491)
8. Brown RW, Warner JJ, Turner BI, et al: Bacteremia and bacteriuria after transrectal prostatic biopsy. Urology 1981; 18: 145-148. (Pubitemid 11033835)
9. Melekos MD: Efficacy of prophylactic antimicrobial regimens in preventing infectious complications after transrectal biopsy of the prostate. Int Urol Nephrol 1990; 22: 257-262.
10. Vallancien G, Prapotnich D, Veillon B, et al: Systemic prostatic biopsies in 100 men with no suspicion of cancer on digital rectal examination. J Urol 1991; 146: 1308-1312.
11. Tuncel A, Aslan Y, Sezgin T, Aydin O, Tekdogan U, Atan A: Does disposable needle guide minimize infectious complications after transrectal prostate needle biopsy? Urology 2008; 71: 1024-1028.
12. Jemal A, Siegel R, Ward E, et al: Cancer statistics, 2007. CA Cancer J Clin 2007; 57: 43-66. (Pubitemid 46148091)
13. Webb NR, Woo HH: Antibiotic prophylaxis for prostate biopsy. BJU Int 2002; 89: 824-828.
14. Fink KG, Schmid HP, Paras L, et al: Prostate biopsy in Central Europe: Results of a survey of indication, patient preparation and biopsy technique. Urol Int 2007; 79: 60-66. (Pubitemid 47051821)
15. Shrimali P, Bhandari Y, Kharbanda S, et al: Transrectal ultrasound-guided prostatic biopsy: Midazolam, the ideal analgesic. Urol Int 2009; 83: 333-336.
16. Hodge KK, McNeal JE, Terris MK: Random systematic versus directed ultrasound guided transrectal core bipopsies. J Urol 1989; 142: 71-74.
17. Chiang IN, Chang SJ, Pu YS, et al: Comparison of 6- and 12-core prostate biopsy in Taiwanese men: Impact of total prostate-specific antigen, prostate-specific antigen density and prostate volume on prostate cancer detection. Urol Int 2009; 82: 270-275.
18. NHS: Diagnostic value of systematic prostate biopsy methods in the investigation of prostate cancer. http://www.cancerscreening. nhs.uk/prostate/pcbs01.html (accessed October 29, 2007).
19. Kapoor DA, Klimberg IW, Malek GH, Wegenke JD, Cox CE, Patterson AL, et al: Single- dose ciprofloxacin versus placebo for prophylaxis during transrectal prostate biopsy. Urology 1998; 52: 552-558.
20. Aron M, Rajeev TP, Gupta NP: Antimicrobial prophylaxis for transrectal needle biopsy of the prostate: A randomized controlled study. BJU Int 2000; 85: 682-685. (Pubitemid 30192834)
21. Sabbagh R, McCormack M, Péloquin F, et al: A prospective randomized trial of 1-day versus 3-day antimicrobial prophylaxis for transrectal ultrasound guided prostate biopsy. Can J Urol 2004; 11: 2216-2219.
22. Shigemura K, Tanaka K, Yasuda M, et al: Efficacy of 1-day prophylaxis medication with fluoroquinolone for prostate biopsy. World J Urol 2005; 23: 356-360. (Pubitemid 43118495)
23. Dirim A, Tekin MI, Koyluoglu E, et al: Do changes in a high serum prostate-specific antigen level and the free/total prostate-specific antigen ratio after antibiotic treatment rule out biopsy and the suspicion of cancer? Urol Int 2009; 82: 266-269.
24. Feliciano J, Teper E, Ferrandino M, Macchia RJ, Blank W, Grunberger I, Colon I: The incidence of fluoroquinolone resistant infections after prostate biopsy - are fluoroquinolones still effective prophylaxis? J Urol 2008; 179: 952-955.
25. Zervos MJ, Hershberger E, Nicolau DP, et al: Relationship between fluoroquinolone use and changes in susceptibility to fluoroquinolones of selected pathogens in 10 United States teaching hospitals, 1991-2000. Clin Infect Dis 2003; 37: 1643-1648. (Pubitemid 37549951)
26. Ellington MJ, Woodford N: Fluoroquinolone resistance and plasmid addiction systems: Self-imposed selection pressure? J Antimicrob Chemother 2006; 57: 1026-1029. (Pubitemid 44644401)
27. Carey JM, Korman HJ: Transrectal ultrasound guided biopsy of the prostate: Do enemas decrease clinically significant complications? J Urol 2001; 166: 82-85.
28. Jeon SS, Woo SA, Hyun JA, et al: Bisacodyl rectal preparation can decrease infectious complications of transrectal ultrasound guided biopsy. Urology 2003; 62: 461-466.
29. Sharpe JR, Sadlowski RW, Finney RP, et al: Urinary tract infection after transrectal needle biopsy of the prostate. J Urol 1982; 127: 255-256. (Pubitemid 12131749)
30. Brown RW, Warner JJ, Turner BI, Haris LF, Alford RH: Bacteremia and bacteriuria after transrectal prostatic biopsy. Urology 1981; 18: 145-148. (Pubitemid 11033835)
31. Akay AF, Akay H, Aflay U, Sahin H, Bircan K: Prevention of pain and infective complications after transrectal prostate biopsy: A prospective study. Int Urol Nephrol 2006; 38: 45-48. (Pubitemid 43299812)
32. Huang YC, Ho DR, Wu CF, Shee JJ, Lin WY, Chen CS: Modified bowel preparation to reduce infection after prostate biopsy. Chang Gung Med J 2006; 29: 395-400.
33. Park DS, Oh JJ, Lee JH, Jang WK, Hong YK, Hong SK: Simple use of the suppository type povidone-iodine can prevent infectious complications in transrectal ultrasoundguided prostate biopsy. Adv Urol 2009, Epub ahead of print.
34. Lessa F, Tak S, Devader SR, Goswami R, Anderson M, Williams I, Gensheimer KF, Srinivasan A: Risk of infections associated with improperly reprocessed transrectal ultrasound- guided prostate biopsy equipment. Infect Control Hosp Epidemiol 2008; 29: 289-293. (Pubitemid 351416976)